CNN - January 12, 2023
Liise-anne Pirofski, M.D., says convalescent plasma, a blood product containing antibodies from people who have recovered from COVID-19, should be among the treatments available to patients with the virus. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore, professor of medicine and of microbiology & immunology, and holds the Selma and Dr. Jacques Mitrani Chair in Biomedical Research at Einstein.
Dr. Pirofski's ProfileMore coverage on Dr. Pirofski
News12 - December 19, 2022
Carlos Rodriguez, M.D., M.P.H., discusses his NIH-funded study that will explore the underlying causes of heart failure among Hispanics/Latinos, who are at heightened risk for heart disease. Dr. Rodriguez is professor of medicine and of epidemiology & population heath at Einstein and director of clinical cardiology research and of cardiovascular epidemiology at Einstein and Montefiore.
Dr. Rodriguez's ProfileMore coverage on Dr. Rodriguez
Medscape - December 12, 2022
Maja Oktay, M.D., Ph.D., comments on her study, presented at the San Antonio Breast Cancer Symposium, which suggests that Black women with a particular type of breast cancer have higher levels of a metastasis marker in their tumors after neoadjuvant chemotherapy, compared with white women. Dr. Oktay is co-leader of the Tuor Microenvironment and Metastasis Program at the NCI-designated Montefiore Einstein Cancer Center, professor of pathology at EInstein, and a pathologist at Montefiore.
Additional coverage includes The ASCO Post
Dr. Oktay's ProfileMore coverage on Dr. Oktay
BronxNet - December 7, 2022
Lynne Holden, M.D., discusses the importance of mentoring and increasing the number of medical students from first generation and immigrant backgrounds and from groups underrepresented in medicine. Dr. Holden is professor of emergency medicine and senior associate dean for diversity and inclusion at Einstein and an emergency medicine physician at Montefiore.
Dr. Holden's ProfileMore coverage on Dr. Holden
The New York Times - November 30, 2022
Harry Ostrer, M.D., says he and colleagues have found that the Ashkenazi Jewish population has become more genetically similar over 700 years. Dr. Ostrer is professor of pathology and of pediatrics at Einstein and director of genetic and genomic testing at Montefiore.
Dr. Ostrer's ProfileMore coverage on Dr. Ostrer
The Boston Globe - November 27, 2022
Sofiya Milman, M.D., M.S., says the SuperAgers Family Study will seek to collect large amounts of data on people aged 95 and older and their children to understand how genes may contribute to longevity and health. Dr. Milman, who is principal investigator of the study, is associate professor of medicine and of genetics, director of human longevity studies at the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Milman's ProfileMore coverage on Dr. Milman
The Washington Post - November 19, 2022
Joe Verghese, M.B.B.S., M.S., explains that while mental processing speed slows as people age, he believes older workers often have better judgment and decision-making ability. Dr. Verghese is chief of the integrated divisions of cognitive and motor aging and of geriatrics at Einstein and Montefiore. He also is the Murray D. Gross Memorial Faculty Scholar in Gerontology, director of the Resnick Gerontology Center, and professor in the Saul R. Korey Department of Neurology and of medicine at Einstein.
Dr. Verghese's ProfileMore coverage on Dr. Verghese
The New York Times - November 19, 2022
Nir Barzilai, M.D., says the age of a candidate should not be the only factor voters consider in an election. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
National Geographic - November 2, 2022
Betsy Herold, M.D., says that long COVID symptoms that children display—including headaches, mood swings, fatigue, and abdominal pain—may be the result of COVID infection and/or a variety of other causes. Dr. Herold is chief of infectious diseases and vice chair for research in the department of pediatrics at Einstein and the Children's Hospital at Montefiore, and the Harold and Muriel Block Chair in Pediatrics at Einstein.
Dr. Herold's ProfileMore coverage on Dr. Herold
The Washington Post - November 1, 2022
Johanna Daily, M.D., M.S., notes the positive results from a study evaluating an antimalarial drug were exciting and that it can potentially play an important role in preventing infection and disease around the world. Dr. Daily is professor of medicine and of microbiology & immunology at Einstein and an infectious disease physician at Montefiore.
Additional coverage includes The Associated Press
Dr. Daily's ProfileMore coverage on Dr. Daily
MedPageToday - October 30, 2022
Fourth-year Einstein medical student Nathan Feiertag discusses his metanalysis, presented at the Sexual Medicine Society of North America's annual meeting, that indicated a link between a plant-based diet and a lower risk of prostate cancer.
The New York Times - October 25, 2022
Jill Crandall, M.D., discusses the link between statins and diabetes risk, noting that the risk is modest, but higher, for those who are prediabetic when they begin taking statins to lower their blood cholesterol levels. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
Time - October 21, 2022
Gabriele de Vos, M.D., M.S., says immunotherapy may not be effective for some people with allergies because it is difficult to develop individual tests—and therefore treatments—to determine the specific causes of a person's allergy. Dr. de Vos is associate professor of medicine at Einstein and an allergist and immunologist at Jacobi Medical Center.
Dr. de Vos' Profile
The Wall Street Journal - October 4, 2022
Kartik Chandran, Ph.D., talks about the need for medical professionals to be ready for future outbreaks of Ebola by working on novel vaccines and drugs that are effective against numerous strains of the virus, rather than only one strain. Dr. Chandran is professor of microbiology & immunology and the Harold and Muriel Block Faculty Scholar in Virology at Einstein.
Additional coverage includes The New York Times and Nature
Dr. Chandran's ProfileMore coverage on Dr. Chandran